NCT03224663 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Franko OI, Tirrell TF
Smartphone app use among medical providers in ACGME training programs. J Med Syst. 2012 Oct;36(5):3135-9. doi: 10.1007/s10916-011-9798-7. Epub 2011 Nov 4.
Thukral A, Joshi M, Joshi P, Prakash V, Adkoli BV, Deorari AK
Apps for management of sick newborn: evaluation of impact on health care professionals. J Trop Pediatr. 2014 Oct;60(5):370-6. doi: 10.1093/tropej/fmu032. Epub 2014 Jun 12.

Module Based Learning and Mobile Application Based Learning Regarding Facility Based Newborn Care Among Nursing Students

Clinical trial NCT03224663 - References